Search by Drug Name or NDC

NDC 57664-0784-88 Clonazepam 0.25 mg/1 Details

Clonazepam 0.25 mg/1

Clonazepam is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is CLONAZEPAM.

MedlinePlus Drug Summary

Clonazepam is used alone or in combination with other medications to control certain types of seizures. It is also used to relieve panic attacks (sudden, unexpected attacks of extreme fear and worry about these attacks). Clonazepam is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 57664-0784-88
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Clonazepam

Product Information

NDC	57664-0784
Product ID	57664-784_1eefcd3c-91bf-4f3c-a43c-5dc1c826b789
Associated GPIs	72100010007215
GCN Sequence Number	051984
GCN Sequence Number Description	clonazepam TAB RAPDIS 0.25 MG ORAL
HIC3	H4A
HIC3 Description	ANTICONVULSANT - BENZODIAZEPINE TYPE
GCN	19468
HICL Sequence Number	001894
HICL Sequence Number Description	CLONAZEPAM
Brand/Generic	Generic
Proprietary Name	Clonazepam
Proprietary Name Suffix	n/a
Non-Proprietary Name	Clonazepam
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, ORALLY DISINTEGRATING
Route	ORAL
Active Ingredient Strength	0.25
Active Ingredient Units	mg/1
Substance Name	CLONAZEPAM
Labeler Name	Sun Pharmaceutical Industries, Inc.
Pharmaceutical Class	Benzodiazepine [EPC], Benzodiazepines [CS]
DEA Schedule	CIV
Marketing Category	ANDA
Application Number	ANDA078654
Listing Certified Through	2024-12-31

Package

NDC 57664-0784-88 (57664078488)

Pricing Information	N/A
NDC Package Code	57664-784-88
Billing NDC	57664078488
Package	100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (57664-784-88)
Marketing Start Date	2017-03-29
NDC Exclude Flag	N